These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10538854)

  • 1. Impact of combination therapy on managed care. Based on a presentation by Lisa Latts, MD, MSPH.
    Am J Manag Care; 1999 Jun; 5(7 Suppl):S456-60; discussion S460-2. PubMed ID: 10538854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of combination therapy. Based on a presentation by Daniel Hilleman, PharmD.
    Am J Manag Care; 1999 Jun; 5(7 Suppl):S449-53; discussion S453-5. PubMed ID: 10538853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost containment for treating hypertension in African Americans: impact of a combined ACE inhibitor-calcium channel blocker.
    Kountz DS
    J Natl Med Assoc; 1997 Jul; 89(7):457-60. PubMed ID: 9220694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of combination therapy in achieving blood pressure control.
    Neutel JM
    Am J Manag Care; 1999 Jun; 5(7 Suppl):S463-8. PubMed ID: 10538855
    [No Abstract]   [Full Text] [Related]  

  • 5. Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy.
    Dickson M; Plauschinat CA
    Am J Cardiovasc Drugs; 2008; 8(1):45-50. PubMed ID: 18303937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving hypertension care in a large group-model MCO.
    Godley P; Nguyen A; Yokoyama K; Rohack J; Woodward B; Chiang T
    Am J Health Syst Pharm; 2003 Mar; 60(6):554-64. PubMed ID: 12659057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations.
    Bramley TJ; Gerbino PP; Nightengale BS; Frech-Tamas F
    J Manag Care Pharm; 2006 Apr; 12(3):239-45. PubMed ID: 16623608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs of current antihypertensive therapy in Switzerland: an economic evaluation of 3,489 patients in primary care.
    Schäfer HH; Scheunert U
    Swiss Med Wkly; 2013; 143():w13854. PubMed ID: 24163048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents.
    Gerbino PP; Shoheiber O
    Am J Health Syst Pharm; 2007 Jun; 64(12):1279-83. PubMed ID: 17563050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roundtable discussion: Part III--Hypertension management in health plans.
    Penna P; Cox E; Joseph T; Lehman L; Morrow T; Richter A; Sowers J; Tepper D
    Manag Care Interface; 2000; Suppl C():24-31. PubMed ID: 11183936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using fixed-dose combination therapies to achieve blood pressure goals.
    Chrysant SG
    Clin Drug Investig; 2008; 28(11):713-34. PubMed ID: 18840014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for antihypertensive medication refill failure by patients under Medicaid managed care.
    Bailey JE; Lee MD; Somes GW; Graham RL
    Clin Ther; 1996; 18(6):1252-62. PubMed ID: 9001841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-pill combinations (SPCs) and treatment of arterial hypertension in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy.
    Tykarski A; Widecka K; Narkiewicz K; Wożakowska-Kapłon B; Gaciong Z; Grajek S; Grodzicki T; Januszewicz A; Wolf J; Prejbisz A; Kostka-Jeziorny K; Filipiak KJ
    Kardiol Pol; 2017; 75(12):1357-1367. PubMed ID: 29251761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany.
    Breitscheidel L; Ehlken B; Kostev K; Oberdiek MS; Sandberg A; Schmieder RE
    J Med Econ; 2012; 15(1):155-65. PubMed ID: 22035215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild-to-moderate uncomplicated hypertension: further analysis of a cost-effectiveness study of five drugs.
    Richter A; Gondek K; Ostrowski C; Dombeck M; Lamb S
    Manag Care Interface; 2001 Jul; 14(7):61-9. PubMed ID: 11481819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of factors influencing blood pressure control in a managed care population.
    Romain TM; Patel RP; Heaberlin AM; Zarowitz BJ
    Pharmacotherapy; 2003 Aug; 23(8):1060-70. PubMed ID: 12921252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats.
    Sica DA
    Drugs; 2002; 62(3):443-62. PubMed ID: 11827559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing costs and improving hypertension management.
    Stankus V; Hemmelgarn B; Campbell NR; Chen G; McAlister FA; Tsuyuki RT
    Can J Clin Pharmacol; 2009; 16(1):e151-5. PubMed ID: 19193969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial medication selection for treatment of hypertension in an open-panel HMO.
    Jerome M; Xakellis GC; Angstman G; Patchin W
    J Am Board Fam Pract; 1995; 8(1):1-6. PubMed ID: 7701954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed-dose triple-combination treatments in the management of hypertension.
    Ram CV
    Manag Care; 2013 Dec; 22(12):45-55. PubMed ID: 24555265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.